SCHEMBL25847427

SCHEMBL25847427

CCc1cccc(NS(=O)(=O)SSS)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 5/20 0.47
▸ CHRNB2 P17787 2/20 0.37
▸ CHRNB4 P30926 2/20 0.37
▸ CHRNA3 P32297 2/20 0.37
▸ CHRNA4 P43681 2/20 0.37
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ ATR Q13535 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ SYK P43405 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ APOBEC3G Q9HC16 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ KCNH2 Q12809 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915228 0.78 HSD11B1 (0.53) HSD11B1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL27183089 0.75 HSD11B1 (0.54) HSD11B1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL24688313 0.74 HSD11B1 (0.50) HSD11B1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL24740725 0.74 HSD11B1 (0.49) HSD11B1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL25832730 0.74 HSD11B1 (0.50) HSD11B1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL5473684 0.69 ALDH1A1 (0.46) HSD11B1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5476374 0.69 ALDH1A1 (0.46) HSD11B1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6602310 0.68 KCNH2 (0.55) HSD11B1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL5476467 0.68 HSD11B1 (0.44) HSD11B1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL27793875 0.68 HSD11B1 (0.62) HSD11B1KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA HSD11B1 1141/4885CHRNB2 4253/4885CHRNB4 3919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback